IVACAFTOR SUN 150mg film-coated tablets medication leaflet

R07AX02 ivacaftor • Respiratory system | Other respiratory system products

Ivacaftor is a medication used for the treatment of cystic fibrosis in patients with specific CFTR gene mutations. It works by improving the function of the CFTR protein, facilitating chloride transport across cell membranes.

The medication is taken orally, usually twice daily with fat-containing food, as directed by a doctor. It is important to follow the treatment regimen to achieve the best results.

Side effects may include headache, abdominal pain, diarrhea, or skin rashes. In rare cases, severe hepatic reactions or elevated liver enzymes may occur.

Ivacaftor is not recommended for patients with hypersensitivity to this medication or severe hepatic impairment.

General data about IVACAFTOR SUN 150mg

Substance: ivacaftor

Date of last drug list: 01-01-2026

Commercial code: W71552001

Concentration: 150mg

Pharmaceutical form: film-coated tablets

Quantity: 28

Product type: generic

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: TERAPIA S.A - ROMANIA

Holder: SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V. - TARILE DE JOS

Number: 16341/2025/01

Shelf life: 3 years

Pharmaceutical forms available for ivacaftor

Concentrations available for ivacaftor

150mg, 25mg, 50mg, 59.5mg, 75mg

Other substances similar to ivacaftor